Formulations comprising an active ingredient and cocoa powder and use thereof
Details for Australian Patent Application No. 2004224557 (hide)
International Classifications
Event Publications
15 September 2005 PCT application entered the National Phase
PCT publication WO2004/084865 Priority application(s): WO2004/084865
24 May 2007 Assignment before Grant
Pfizer Health AB The application has been assigned to Pfizer Consumer Healthcare Health AB
26 July 2007 Change of Name(s) of Applicant(s), Section 104
Pfizer Consumer Healthcare Health AB The name of the applicant has been changed to McNeil AB
18 June 2009 Application Accepted
Published as AU-B-2004224557
22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
26 November 2009 Section 223 Application Allowed
McNeil AB The time in which to pay the acceptance fee has been extended to 18 Nov 2009. Address for service in Australia - Allens Arthur Robinson Patent & Trade Marks Attorneys Deutsche Bank Place Corner Hunter and Phillip Streets Sydney NSW 2000
3 December 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004224562-Modulation of cell death
2004224556-Formulations comprising tolterodine and cocoa powder and use thereof
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser